PBLS
Parabilis Medicines, Inc. • NASDAQ
$30.04 ▲ 10.00% (+2.73)
PBLS
Parabilis Medicines, Inc.NASDAQ • $30.04 ▲ 10.00% (+2.73)
Market Cap $98.59 M
52w High $34.47
52w Low $24.51
P/E -34.14
Volume 219.69K
Outstanding Shares 3.27M
Market Cap $98.59 M
52w High $34.47
52w Low $24.51
P/E -34.14
Volume 219.69K
Outstanding Shares 3.27M
About Parabilis Medicines, Inc.
http://www.parabilismed.comFog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.
CEO
Mathai Mammen
Compensation Summary
(Year )
Total Compensation (Unknown At The Moment)
Industry Biotechnology
Sector Healthcare
Went public June 10, 2026
Method of going public IPO
Full time employees 145
SEP
2 WED
Upcoming Earnings
Date Sep 2, 2026
Day Wednesday
Revenue Est. $16.67M
ETFs Holding This Stock
Summary
Total 16
Showing Top 3 of 16
Price Target
Target High $40
Target Low $40
Target Median $40
Target Consensus $40